Bendtzen, Klaus
Rigshospitalet,
Denmark
2023 Rank: 131330
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2702 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 131330 | 149873 |
| Total Cites | 497 | 536 |
| H-index | 8 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 51 | 51 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 108 | 108 |
| Total Cites to Single+First Authored Papers | 53 | 53 |
| Number of Single+First+Last Authored Papers | 276 | 276 |
| Total Cites to Single+First+Last Authored Papers | 166 | 181 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 437 | 449 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.19 |
| Self-Citation Percentage |
7.28%
|
|
Bendtzen, Klaus
Rigshospitalet,
Denmark
2022 Rank: 83588
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2015 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83588 | 92799 |
| Total Cites | 627 | 642 |
| H-index | 9 | 10 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 51 | 51 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 108 | 108 |
| Total Cites to Single+First Authored Papers | 50 | 50 |
| Number of Single+First+Last Authored Papers | 275 | 275 |
| Total Cites to Single+First+Last Authored Papers | 180 | 181 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 531 | 545 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.18 |
| Self-Citation Percentage |
2.34%
|
|
Bendtzen, Klaus
Rigshospitalet,
Denmark
2021 Rank: 74991
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 1685 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74991 | 81434 |
| Total Cites | 924 | 990 |
| H-index | 13 | 14 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 51 | 51 |
| Total Cites to Single Authored Papers | 26 | 27 |
| Number of Single+First Authored Papers | 107 | 107 |
| Total Cites to Single+First Authored Papers | 77 | 79 |
| Number of Single+First+Last Authored Papers | 274 | 274 |
| Total Cites to Single+First+Last Authored Papers | 264 | 281 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 783 | 813 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.22 |
| Self-Citation Percentage |
6.67%
|
|
Bendtzen, Klaus
Rigshospitalet,
Denmark
2020 Rank: 61874
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1344 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61874 | 61170 |
| Total Cites | 720 | 783 |
| H-index | 11 | 12 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 51 | 51 |
| Total Cites to Single Authored Papers | 29 | 30 |
| Number of Single+First Authored Papers | 107 | 107 |
| Total Cites to Single+First Authored Papers | 77 | 80 |
| Number of Single+First+Last Authored Papers | 273 | 273 |
| Total Cites to Single+First+Last Authored Papers | 232 | 253 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 593 | 622 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.26 |
| Self-Citation Percentage |
8.05%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.